Cadmium Exposure in Pregnancy and Its Effect on Fetal Growth
Official title: Cadmium Exposure During Pregnancy and Fetal Growth
Run by Centre Hospitalier Universitaire, Amiens · NCT07855237 · Data updated 2026-11-12
This observational study follows pregnant people to see how cadmium exposure relates to fetal growth and birth weight.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 50 (estimated) |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens) |
| Status | Recruiting |
| Started | September 21, 2026 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07855237 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women aged 18 or older with singleton pregnancies planning delivery at CHU Amiens, who can provide informed consent under French non-interventional research rules.
✕Probably not a fit
Participants with low cadmium exposure or whose outcomes are not affected by exposure levels may not experience direct benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This non-interventional study collects maternal blood, urine, and placental tissue to measure cadmium exposure during pregnancy and to examine associations with placental function and fetal growth. It leverages a single-center population at CHU Amiens in France and uses observational methods to relate exposure levels to birth outcomes. The study provides biomonitoring data and aims to understand exposure pathways and potential risks to neonatal health. No experimental treatment is given; the effort focuses on observational correlations in a real-world setting.
Why it matters
Potential benefit: Findings could improve understanding of how cadmium exposure affects fetal growth and inform public health strategies to reduce risk.
How similar studies have gone: Previous research has linked placental cadmium exposure to adverse fetal outcomes, supporting the relevance of this observational approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women aged 18 years or older * Singleton pregnancy * Planned delivery at the maternity unit of Amiens University Hospital (CHU Amiens) * Ability to receive study information and provide informed non-opposition/consent according to French regulations for non-interventional research Exclusion Criteria: * Women under legal protection measures, including guardianship, curatorship, or judicial safeguard * Inability to understand the study objectives or the constraints of the protocol (language barrier, cognitive impairment, or other reasons) * Lack of affiliation to a social security system, as required by French regulations
Where it's running
-
CHU Amiens Picardie
Amiens, France Recruiting
Study contacts
- Study coordinator: Rosalie CABRY, Pr
- Email: cabry.rosalie@chu-amiens.fr
- Phone: 33+3 22 08 73 70
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Probiotic supplement to lower serum PFAS levels in male firefighters
A probiotic supplement containing Streptococcus salivarius is being tested to see if it lowers PFAS levels in male firefighters who have been exposed to PFAS.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
-
PNEUMO-LIBS: Using tissue imaging and AI to explore causes of chronic lung diseases
This study tests whether multi-element tissue imaging with LIBS, plus the AI tool IFF, can help doctors understand possible causes of chronic lung diseases in adults who have had a lung biopsy.
-
How the placenta affects maternal and fetal health
This project will test whether tiny particles released by the placenta differ in pregnancies with pre-eclampsia, gestational diabetes, or fetal growth restriction compared with healthy pregnancies and non-pregnant women.
-
Environmental and lifestyle effects on IVF and fertility treatment success
This project will try to see if everyday environmental chemicals (like from plastics or air pollution) and personal habits (like diet and stress) change the chances of pregnancy and live birth for couples using fertility treatments such as IVF.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.